探索[d]-2-胺衍生物,合成和分子对接洞察力 潜在的抗癌剂 准 HER 酶和 DNA
Ammar M K Al-Azzawi1, Ekhlas Abdallah Hassan2
1Department of Chemistry, College of Education for Pure Science, University of Diyala, Baqubah, Iraq.
Applied biochemistry and biotechnology
|January 3, 2025
概括
研究人员合成了新的[d]醇-2-胺衍生物,并评估了它们作为癌症治疗药物的潜力. 化合物2和3对人体表皮生长因子受体 (HER) 酶和DNA表现出显著的结合亲和力,这表明癌症治疗具有前途.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 药物发现 药物发现 药物发现
背景情况:
- [d]thiazol-2-amine衍生物正在研究它们的潜在治疗应用.
- 了解类似药物的特性和生物活动对于开发新疗法至关重要.
- 分子对接研究为药物向相互作用提供了洞察力.
研究的目的:
- 为了合成和表征新的[d]thiazol-2-amine衍生物.
- 评估合成化合物的类似药物的特性和生物活性.
- 进行分子对接研究,以评估与人表皮生长因子受体 (HER) 酶和DNA的结合 afinities.
主要方法:
- 通过化学反应合成[d]醇-2-胺衍生物.
- 使用红外光谱和点测定进行结构性表征.
- 使用AutoDock Vina进行分子对接模拟,以预测结合相互作用.
主要成果:
- 化合物2和3与化合物1相比,对HER酶具有更高的结合亲和力.
- 化合物2表现出最高的结合亲和度得分,这表明HER酶相互作用的强大潜力.
- 合成的化合物显示出对细菌菌株的多样化生物活性.
结论:
- 化合物2和3显示出作为抗癌剂的显著潜力,因为它们与HER和DNA具有强烈的结合亲和力.
- 这些衍生品的结构特征有助于它们有前途的治疗潜力.
- 需要进一步的研究来探索它们在癌症治疗中的有效性.
相关概念视频
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
219
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
219
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
201
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
201
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
Electron Transport Chain: Complex I and II
11.1K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
11.1K


